Free Trial
Portfolio Monitoring Tools for the A.I. EraStart Free For 30 Days

Bausch Health Companies (TSE:BHC) Stock Price Down 1.7% - Time to Sell?

Written by MarketBeat
Updated September 20, 2025
Bausch Health Companies logo with Medical background

Key Points

  • Bausch Health Companies Inc.'s stock price fell by 1.7%, trading between C$9.71 and C$9.89, with a total of 337,684 shares exchanged, a decrease from the average volume.
  • The company's market capitalization stands at C$3.66 billion and it has a price-to-earnings ratio of 38.04.
  • Bausch Health primarily develops and markets products in the therapeutic areas of eye health, gastroenterology, and dermatology.
  • Five stocks we like better than Bausch Health Companies.

Bausch Health Companies Inc. (TSE:BHC - Get Free Report) shares were down 1.7% during trading on Monday . The stock traded as low as C$9.71 and last traded at C$9.89. Approximately 337,684 shares changed hands during trading, a decline of 10% from the average daily volume of 376,599 shares. The stock had previously closed at C$10.06.

Bausch Health Companies Trading Down 2.5%

The firm has a market capitalization of C$3.44 billion, a price-to-earnings ratio of 35.73, a P/E/G ratio of 0.21 and a beta of 0.48. The company has a debt-to-equity ratio of -1,831.94, a current ratio of 1.19 and a quick ratio of 0.58. The firm's 50-day simple moving average is C$9.50 and its 200 day simple moving average is C$8.45.

About Bausch Health Companies

(Get Free Report)

Bausch Health Companies Inc is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health.

See Also

Should You Invest $1,000 in Bausch Health Companies Right Now?

Before you consider Bausch Health Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bausch Health Companies wasn't on the list.

While Bausch Health Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best Nuclear Energy Stocks to Buy Cover
The Best Nuclear Energy Stocks to Buy

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.